CD44 and prostate carcinoma: In one of the studies performed in vitro and in vivo on cell lines and xenograft tumor models, Patrawala et al. [70] showed that CD44+ prostate cancer stem cells have stem—like properties such as increased clonoge nic and metastatic potential.